Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.13%
#3 CoW Protocol CoW Protocol +44.52%
#4 Glidr Glidr +36.87%
#5 Walrus Walrus +25.11%
#6 Humanity Humanity +23.63%
#7 Enso Enso +19.41%
#8 Codatta Codatta +18.73%
#9 Collector Crypt Collector Crypt +14.19%
#10 The Black Bull The Black Bull +12.76%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Rank in Stocks #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Share Price
$0.117
Last synced: 2025-04-04
Market Cap
$2.45M
Change (1 day)
-13.59%
Change (1 year)
0.00%
Country
US
Trade Carmell Therapeutics Corporation (CTCX)

Category

Healthcare
Operating Margin for Carmell Therapeutics Corporation (CTCX)
Operating Margin as of August 2026 TTM: -343.58%
According to Carmell Therapeutics Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is -343.58%. At the end of 2023 the company had an Operating Margin of 0.00%.
Operating Margin history for Carmell Therapeutics Corporation from 2021 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -343.58% -96.54%
2024 -9,933.82% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -100.11%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.08%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.09%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.